Abstracts tagged "menopause and rheumatoid arthritis (RA)"

Abstract Number: 1500 • 2015 ACR/ARHP Annual Meeting
Impact of Menopause on Functional Impairment of Rheumatoid Arthritis Patients
Naglaa Hussein¹ and Abdelmoneim Helal², ¹physical medicine, rheumatology &rehabilitation, Alexandria university, Alexandria, Egypt, ²Physical Medicine, Rheumatology & rehabilitation, Professor, Alexandria, Egypt
Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune disease which is predominant in female with female to male ration ranging between 2:1 to 3:1. The peak…
Abstract Number: 2825 • 2013 ACR/ARHP Annual Meeting
The Influence Of Early Menopause On Cardiovascular Risk In Women With Rheumatoid Arthritis
Emily Pfeifer¹, Cynthia S. Crowson², Shreyasee Amin³, Sherine E. Gabriel⁴ and Eric L. Matteson⁵, ¹Department of Medicine, Mayo Clinic, Rochester, MN, ²Department of Health Sciences Research, Mayo Clinic, Rochester, MN, ³Division of Rheumatology, Mayo Clinic, Rochester, MN, ⁴Health Sciences Research & Div of Rheumatology, Mayo Clinic, Rochester, MN, ⁵Rheumatology, Mayo Clinic, Rochester, MN
Background/Purpose: Lifetime exposure to female sex hormones may play a role in the development and severity of rheumatoid arthritis (RA). These same hormones have also…
Abstract Number: 374 • 2013 ACR/ARHP Annual Meeting
Effect Of Age At Menopause In Women With Early Rheumatoid Arthritis
Lauren Wong¹, Wei-Ti Huang², Juan Xiong³, Gilles Boire⁴, Boulos Haraoui⁵, Janet E. Pope⁶, J. Carter Thorne⁷, Carol A. Hitchon⁸, Diane Tin⁹, Edward Keystone¹⁰ and Vivian P. Bykerk¹¹, ¹Rheumatology, Hospital for Special Surgery, New York, NY, ²Biostatistics, Hospital for Special Surgery, New York, NY, ³Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, ⁴Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, Canada, ⁵Rheumatology, Institut de Rhumatologie de Montréal, Montreal, QC, Canada, ⁶Medicine/Rheumatology, St. Joseph's Health Care, University of Western Ontario, London, ON, Canada, ⁷Southlake Regional Health Centre, Newmarket, ON, Canada, ⁸University of Manitoba, Winnipeg, MB, Canada, ⁹The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, ¹⁰Mount Sinai Hospital, Toronto, ON, Canada, ¹¹Divison of Rheumatology, Hospital for Special Surgery, New York, NY
Background/Purpose: Rheumatoid arthritis (RA) preferentially affects women and studies suggest that various hormonal and reproductive factors may affect disease onset and severity. This study assessed…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].